1. Home
  2. ENTA vs XWIN Comparison

ENTA vs XWIN Comparison

Compare ENTA & XWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$15.22

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

XWIN

XMAX Inc.

N/A

Current Price

$8.37

Market Cap

353.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
XWIN
Founded
1995
2003
Country
United States
United States
Employees
N/A
22
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
353.6M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
XWIN
Price
$15.22
$8.37
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
123.3K
986.7K
Earning Date
05-11-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$5.55
$5.20
52 Week High
$17.15
$8.27

Technical Indicators

Market Signals
Indicator
ENTA
XWIN
Relative Strength Index (RSI) 67.77 85.44
Support Level $12.91 $5.58
Resistance Level $15.37 N/A
Average True Range (ATR) 0.76 0.21
MACD 0.16 0.06
Stochastic Oscillator 81.47 95.88

Price Performance

Historical Comparison
ENTA
XWIN

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About XWIN XMAX Inc.

XMax Inc is a designer and lifestyle furniture company. The company is a designer and distributor of contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. The company plans expansion into artificial intelligence (AI) while continuing to operate and develop its existing furniture business.

Share on Social Networks: